4/26
02:35 pm
ppbt
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Low
Report
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
4/25
07:12 am
ppbt
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting [Yahoo! Finance]
Low
Report
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting [Yahoo! Finance]
4/25
07:00 am
ppbt
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
High
Report
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting
3/28
07:09 am
ppbt
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024 [Yahoo! Finance]
Medium
Report
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024 [Yahoo! Finance]
3/28
07:00 am
ppbt
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
Medium
Report
Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
3/14
07:52 am
ppbt
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology [Yahoo! Finance]
Medium
Report
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology [Yahoo! Finance]
3/14
07:30 am
ppbt
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
Medium
Report
Purple Biotech Reports Preclinical Proof of Concept for its Tribody Platform Technology
3/5
01:01 pm
ppbt
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Neutral
Report
Purple Biotech Ltd. (NASDAQ: PPBT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
5/2
04:15 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: May 02
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: May 02
4/25
07:10 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Apr 25
High
Report
Form 6-K PURPLE BIOTECH LTD. For: Apr 25
4/3
06:03 am
ppbt
Form EFFECT PURPLE BIOTECH LTD.
Low
Report
Form EFFECT PURPLE BIOTECH LTD.
3/28
04:02 pm
ppbt
Form POS AM PURPLE BIOTECH LTD.
Medium
Report
Form POS AM PURPLE BIOTECH LTD.
3/28
07:10 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Mar 28
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Mar 28
3/14
07:40 am
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Mar 14
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Mar 14
3/6
04:08 pm
ppbt
Form 6-K PURPLE BIOTECH LTD. For: Mar 06
Medium
Report
Form 6-K PURPLE BIOTECH LTD. For: Mar 06
3/5
04:01 pm
ppbt
Form 20-F PURPLE BIOTECH LTD. For: Dec 31
Low
Report
Form 20-F PURPLE BIOTECH LTD. For: Dec 31
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register